Postmenopausal hormone therapy, SERMs, and coronary heart disease in women

J Endocrinol Invest. 1999 Sep;22(8):616-24. doi: 10.1007/BF03343619.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Coronary Disease / prevention & control*
  • Estrogen Replacement Therapy*
  • Female
  • Humans
  • Postmenopause*
  • Progestins / adverse effects
  • Randomized Controlled Trials as Topic
  • Selective Estrogen Receptor Modulators / therapeutic use*

Substances

  • Progestins
  • Selective Estrogen Receptor Modulators